GlassScriptPhysician profile
Boleslav Kotlyar
NPI 1386986669
$8,185.18
in general payments reported to CMS, 2019-2025
19 companies · $1,186 in 2025
The $1,186 reported for 2025 was more than what 77% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $768 · 2020: $239 · 2021: $331 · 2022: $719 · 2023: $1,001 · 2024: $3,942 · 2025: $1,186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,747 · Consulting Fee: $2,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,746.83 |
| Consulting Fee | $2,382.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $2,628.79 | 2024-2025 | Izervay |
| Regeneron Healthcare Solutions, INC. | $2,212.03 | 2019-2025 | Eylea Hd, Eylea |
| Bausch & Lomb Americas INC. | $629.42 | 2022-2025 | Stellaris, Envista Mx60 Iol, Stellaris Elite |
| Alimera Sciences, INC. | $585.69 | 2020-2024 | Iluvien, Yutiq |
| Abbvie INC. | $342.48 | 2022-2025 | |
| Alcon Vision LLC | $282.04 | 2019-2025 | Hydrus Microstent, Unity |
| Novartis Pharmaceuticals Corporation | $270.92 | 2019 | |
| Sight Sciences, INC. | $201.69 | 2024 | Omni Surgical System |
| Genentech USA, INC. | $178.27 | 2022-2025 | Vabysmo, Lucentis |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $174.25 | 2019-2020 | |
| Eyepoint US, INC. | $129.57 | 2022-2023 | |
| Neurotech Pharmaceuticals, INC. | $126.27 | 2025 | |
| Allergan, INC. | $123.91 | 2019 | |
| Biogen, INC. | $71.86 | 2023-2024 | Byooviz |
| Apellis Pharmaceuticals, INC. | $70.53 | 2023-2025 | Syfovre |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $65.71 | 2025 | Iluvien, Purified Cortrophin Gel, Yutiq |
| Mallinckrodt Hospital Products INC. | $44.20 | 2020 | |
| Mallinckrodt Enterprises LLC | $29.38 | 2019 | |
| Harrow Eye, LLC | $18.17 | 2025 | Iheezo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boleslav Kotlyar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.